🎉 M&A multiples are live!
Check it out!

Bruker Valuation Multiples

Discover revenue and EBITDA valuation multiples for Bruker and similar public comparables like InfuSystem, SmartVest, and Perspective Therapeutics.

Bruker Overview

About Bruker

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.


Founded

1991

HQ

United States of America
Employees

9.7K+

Website

bruker.com

Financials

LTM Revenue $3.4B

LTM EBITDA $627M

EV

$8.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Bruker Financials

Bruker has a last 12-month revenue of $3.4B and a last 12-month EBITDA of $627M.

In the most recent fiscal year, Bruker achieved revenue of $3.4B and an EBITDA of $439M.

Bruker expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Bruker valuation multiples based on analyst estimates

Bruker P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $3.0B $3.4B XXX XXX XXX
Gross Profit $1.3B $1.5B XXX XXX XXX
Gross Margin 44% 45% XXX XXX XXX
EBITDA $676M $439M XXX XXX XXX
EBITDA Margin 23% 13% XXX XXX XXX
Net Profit $297M $427M XXX XXX XXX
Net Margin 10% 13% XXX XXX XXX
Net Debt $574M $793M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Bruker Stock Performance

As of April 15, 2025, Bruker's stock price is $40.

Bruker has current market cap of $6.1B, and EV of $8.1B.

See Bruker trading valuation data

Bruker Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$8.1B $6.1B XXX XXX XXX XXX $2.47

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Bruker Valuation Multiples

As of April 15, 2025, Bruker has market cap of $6.1B and EV of $8.1B.

Bruker's trades at 2.4x LTM EV/Revenue multiple, and 13.0x LTM EBITDA.

Analysts estimate Bruker's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Bruker and 10K+ public comps

Bruker Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $8.1B XXX XXX XXX
EV/Revenue 2.4x XXX XXX XXX
EV/EBITDA 18.5x XXX XXX XXX
P/E 53.5x XXX XXX XXX
P/E/Growth 0.5x XXX XXX XXX
EV/FCF 59.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Bruker Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Bruker Valuation Multiples

Bruker's NTM/LTM revenue growth is 4%

Bruker's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Bruker's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Bruker's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Bruker and other 10K+ public comps

Bruker Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 14% XXX XXX XXX XXX
EBITDA Margin 13% XXX XXX XXX XXX
EBITDA Growth -35% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 17% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 11% XXX XXX XXX XXX
Opex to Revenue 38% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Bruker Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Bruker M&A and Investment Activity

Bruker acquired  XXX companies to date.

Last acquisition by Bruker was  XXXXXXXX, XXXXX XXXXX XXXXXX . Bruker acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Bruker

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Bruker

When was Bruker founded? Bruker was founded in 1991.
Where is Bruker headquartered? Bruker is headquartered in United States of America.
How many employees does Bruker have? As of today, Bruker has 9.7K+ employees.
Who is the CEO of Bruker? Bruker's CEO is Dr. Frank H. Laukien,PhD.
Is Bruker publicy listed? Yes, Bruker is a public company listed on NAS.
What is the stock symbol of Bruker? Bruker trades under BRKR ticker.
When did Bruker go public? Bruker went public in 2000.
Who are competitors of Bruker? Similar companies to Bruker include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Bruker? Bruker's current market cap is $6.1B
What is the current revenue of Bruker? Bruker's last 12-month revenue is $3.4B.
What is the current EBITDA of Bruker? Bruker's last 12-month EBITDA is $627M.
What is the current EV/Revenue multiple of Bruker? Current revenue multiple of Bruker is 2.4x.
What is the current EV/EBITDA multiple of Bruker? Current EBITDA multiple of Bruker is 13.0x.
What is the current revenue growth of Bruker? Bruker revenue growth between 2023 and 2024 was 14%.
Is Bruker profitable? Yes, Bruker is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.